Background {#S0001}
==========

Trachoma, the leading infectious cause of blindness worldwide,^[1](#CIT0001)^ is a chronic kerato-conjunctivitis caused by the bacterium *Chlamydia trachomatis*.^[2](#CIT0002)^ Infections, most commonly occurring in children,^[3](#CIT0003)^ may lead to sub-epithelial follicles or more pronounced inflammation.^[4](#CIT0004)^ Repeated infection^[5](#CIT0005),[6](#CIT0006)^ can lead to scarring of the conjunctivae^[7](#CIT0007)^ which, when severe enough, can deform the eyelid and cause eyelashes to touch the globe (trichiasis).^[4](#CIT0004)^ Uncorrected trichiasis can result in corneal abrasion, ulceration, opacification, and potentially, vision loss and blindness.

In 1993, the World Health Organization (WHO) endorsed the SAFE strategy,^[8](#CIT0008)^ a comprehensive management plan for elimination of trachoma as a public health problem. SAFE refers to surgery (S) to correct trichiasis, mass distribution of antibiotics (A) to clear infection, and facial cleanliness (F) and environmental improvement (E) to reduce *C. trachomatis* transmission.^[9](#CIT0009)^ To determine whether public health-level interventions are required, population-based surveys to generate prevalence estimates of trachomatous inflammation---follicular (TF) and trichiasis are recommended.^[10](#CIT0010),[11](#CIT0011)^

Chad is a central African country of approximately 12 million people spread across three distinct ecologic zones: the Sahara Desert, the Sahel, and the Savanna. Currently the country has a total of 33 ophthalmic nurses; 35 ophthalmic technicians; and nine ophthalmologists (approximately one for every 1.5 million people) of whom 5 are in the capital N'Djamena. Though absolute numbers of eye-care personnel are low, Chad is fortunate that 90% of them work in the public sector -- specifically in five departments of ophthalmology (within two secondary and three tertiary hospitals) and 21 secondary eye care units.

A number of population-based trachoma prevalence surveys were undertaken in Chad in 1984,^[12](#CIT0012)^ 1985,^[13](#CIT0013)^ 2001^[14](#CIT0014)^ and 2004^[15](#CIT0015)^ ([Table 1](#T0001)); however, due to financial constraints, SAFE strategy implementation was not commenced until 2015. The 1984--2004 surveys occurred prior to the recent growth in interest in trachoma elimination,^[17](#CIT0017)^ and were conducted at region level, covering large populations and wide geographical areas ([Table 1](#T0001)). Because of the age and relatively low resolution of existing data, in order to inform programmatic action, baseline mapping or re-mapping was felt to be required.^[18](#CIT0018)^ We set out to estimate the prevalence of TF in 1--9-year-olds and the prevalence of trichiasis in adults in population units of 100,000--250,000 people in suspected-trachoma-endemic areas of rural Chad. 10.1080/09286586.2018.1546877-T0001Table 1.Findings from trachoma prevalence surveys in Chad, 1984--2004.Region(s) surveyedYear survey completedEstimated population at time of surveyActive trachoma indicator reportedNumber of 0--9-year-olds examinedActive trachoma prevalence in\
0--9-year-olds (%) \[95% CI\]^b^Trichiasis indicator\
reportedNumber of adults examinedTrichiasis prevalence in (%)^b^RefLac and Kanem1984322,289F~3~P~3~ or F~3~P~2~^a^21330.5Trichiasis in ≥ 15-year-olds2565.5^[12](#CIT0012)^Ouaddaï and Biltine19851,558,953F~3~P~3~ or F~3~P~2~^a^21127.5Trichiasis in ≥ 15-year-olds3143.5^[13](#CIT0013)^Lac, Kanem, Chari Baguirmi20011,798,240TF204633.2 \[29.2--37.5\]Trichiasis in ≥ 15-year-old ♀s12521.3^[14](#CIT0014)^Ouaddaï and Biltine20011,663,512TF190629.7 \[25.6--34.1\]Trichiasis in ≥ 15-year-old ♀s12401.7^[14](#CIT0014)^Moyen Chari2004757,127TF240917.5Trichiasis in ≥ 15-year-old ♀s16261.4^[15](#CIT0015)^Guéra and Salamat20041,072,034TF211926.9Trichiasis in ≥ 15-year-old ♀s16056.2^[15](#CIT0015)^[^3][^4]

Materials and methods {#S0002}
=====================

Administratively, Chad is divided into 23 regions. Each region (other than the capital, N'Djamena, which has a different internal administrative structure) is divided into two to six health districts, the level at which trachoma elimination activities are implemented.^[19](#CIT0019)^ There are 61 health districts in total, of which 45 were suspected to have trachoma as a public health problem and therefore to qualify for mapping, based on criteria published elsewhere.^[20](#CIT0020)^ Surveys were conducted in 2014 and 2015. Due to insecurity prevailing at that time, five suspected-trachoma-endemic health districts (Bol and Ngouri in Lac Region, Nokou in Kanem Region, Mandelia in Chari Baguirmi Region and Bardaï in Tibesti Region) could not be surveyed.

Survey design, field team training and certification, fieldwork, and data handling were conducted according to the systems and methodologies of the Global Trachoma Mapping Project (GTMP).^[20](#CIT0020)--[23](#CIT0023)^ Each of the 40 secure health districts was generally surveyed as a single evaluation unit (EU), though six health districts with populations (estimated using 2009 population census data^[24](#CIT0024)^ and a mean annual population growth rate of 3.6%) significantly larger than the standard 100,000--250,000-person EU were divided into two EUs each, resulting in a total of 46 independent EUs.

Village-level population estimates were provided by the Division of Health & Information Systems. According to the 2009 census,^[24](#CIT0024)^ the proportion of the population aged 1--9 years was 36% and rural households had a mean of 5.3 residents. The estimated sample size requirement per EU was based on an expected TF prevalence of 10% in children aged 1--9 years, a design effect of 2.65, and a desire to be 95% confident of estimating the TF prevalence with ± 3% absolute precision.^[22](#CIT0022)^ The resulting sample size (*n* = 1019) was increased by 20% to account for non-response; this resulted in a total of 649 households being required per EU.

Using a two-stage cluster-sampling design, 22 clusters (villages or neighbourhoods) were systematically selected in each EU using probability-proportional-to-population-size sampling. In each cluster, compact segment sampling^[25](#CIT0025),[26](#CIT0026)^ was then used to select 30 households. All residents over the age of 12 months who had resided for at least six months in selected households were eligible for enrolment.

A survey team consisted of a grader (ophthalmic technician), a recorder (high school graduate at ease with Android smart phones and fluent in major local languages), a local facilitator and a driver. Members of the survey team underwent standardized GTMP training, using version 2 of the system.^[27](#CIT0027)^ Candidate graders were assessed after training, and only those obtaining a kappa of ≥ 0.7 for diagnosis of TF in an inter-grader agreement test with a GTMP-certified grader trainer were accepted as survey graders. Trachoma grading was done according to the WHO simplified grading system.^[4](#CIT0004)^ Graders used 2.5× magnifying binocular loupes and sunlight illumination to examine consenting residents. In eyes diagnosed as having trichiasis, the presence or absence of trachomatous conjunctival scarring^[28](#CIT0028),[29](#CIT0029)^ was not recorded, so we are unable to confirm that trichiasis cases detected were due to trachoma; consequently, we refer here to the prevalence of trichiasis instead of the prevalence of trachomatous trichiasis. Each survey team was trained to ask questions relating to access to water and sanitation at each selected household.^[27](#CIT0027)^

All data were captured electronically, through the Open Data Kit-based Android phone application purpose-built for the GTMP. Once saved, data were sent to and stored on the GTMP Cloud-based secure server, then cleaned and analyzed.^[22](#CIT0022)^ For each survey cluster, the proportion of 1--9-year-old children with TF was adjusted by age in one-year age bands, while the proportion of ≥ 15-year-olds with trichiasis was adjusted by age and gender in five-year age bands; age and gender data from the 2009 Chad census were used as the reference population for this purpose.^[24](#CIT0024)^ For each EU, the primary outcome of interest was the age-adjusted prevalence of TF in 1--9-year-olds; intended secondary outcomes were the age- and gender-adjusted prevalence of trichiasis in ≥ 15-year-olds, and household-level access to water and sanitation. Confidence intervals for TF and trichiasis prevalence estimates were calculated by bootstrapping sets of 22 adjusted cluster-level proportions for each sign, with replacement, over 10,000 replicates, and taking the 2.5th and 97.5th centiles of the ordered results. Additional gender-specific age-adjusted estimates of trichiasis prevalence, with 95% confidence intervals, were calculated in analogous fashion. The ratio of trichiasis prevalence in females to that in males in each EU was also determined, and linear regression modelling (Stata 11, College Station TX, USA) used to generate an intra-class correlation coefficient, to assess the association between EU-level trichiasis prevalence and ratio of gender-specific prevalences.

Ethical clearance was obtained from the Chadian Ethical Committee for Applied Research, led by the Ministry of Higher Education; and from the London School of Hygiene & Tropical Medicine (6319). The examination procedure was explained to each eligible adult in the local language and verbal consent for enrolment and examination was obtained. For eligible children, verbal consent was obtained from a parent or guardian. Individuals with active trachoma were offered 1% tetracycline ointment for application into the conjunctival sac twice-daily for six weeks. Individuals with trichiasis were offered management by a surgeon.

Results {#S0003}
=======

Fieldwork was undertaken from May 2014 to November 2015. At a subsequent field team meeting, it emerged that fieldworkers had considered their main task to be the acquisition of information on TF and trichiasis. Contrary to the survey protocol and the standard GTMP training package, in some villages, questions about access to water and sanitation had not been systematically asked in each selected household. Rather, information had been collected from the head of the village at the beginning of the day and those answers used for each household visited. Although this shortcut was not employed by all teams, it cast doubt on the accuracy of our water and sanitation data, and we do not include those data in this manuscript. Data cleaning revealed inconsistency in definitions of EU and district boundaries. In particular, in three health districts (Pala, Béré & Kélo, and Donomanga & Laï) that had each been split into two EUs, GPS data revealed considerable overlap between clusters that had ostensibly been drawn from separate EUs. Data from these pairs of within-health-district EUs were therefore combined to re-constitute health-district-level EUs; the numbers of clusters finally included in each EU are shown in [Table 2](#T0002). GPS data^[30](#CIT0030)^ were not received at all from a high proportion of households mapped in both of Moundou's two EUs; those that had GPS data were geolocated in a pattern inconsistent with known administrative divisions. For that reason, the data from Moundou did not pass GTMP quality control, and the outputs were, as expected, rejected by the health ministry. We therefore present data here from what became a total of 41 surveys.10.1080/09286586.2018.1546877-T0002Table 2.Numbers of children and adults enumerated and examined, by evaluation unit, Global Trachoma Mapping Project, Chad, 2014--2015.RegionEvaluation unit (label in [Figures 1](#F0001) and [2](#F0002))PopulationNumber of clusters enrolledNumber of households enrolledNumber of 1--9-year-olds enumeratedNumber of 1--9-year-olds\
absentNumber of 1--9-year-olds refusedNumber of 1--9-year- olds examinedNumber of ≥ 15-year-olds enumeratedNumber of ≥ 15-year-olds absentNumber of ≥ 15-year-olds refusedNumber of ≥ 15-year-olds examinedBathaAti (1)274,7812265913240013241050001050BathaOum Hadjer (2)233,22322651114320114184013836BathaYao (3)143,61622649131911131793509926Logone OccidentalLaokassy (4)105,6302267414790014791127101126Logone OccidentalBénoye (5)215,9592267112401012391111001111Logone OrientalDoba (6)276,0452265611450011451072021070Logone OrientalBéboto (7)138,0222368311620011621238101237Logone OrientalBébédjia (8)156,476226539870997894613942Logone OrientalGoré (9)188,8242266210114999887824872Logone OrientalBessao (10)225,36622656112716112093703934Mayo Kebbi EstBongor (11)249,29022621126320126186320861Mayo Kebbi EstGounou Gaya (12)289,41222121727420027421233001233Mayo Kebbi EstGuélengdeng (13)124,644226729840198391101910Mayo Kebbi EstFianga (14)287,66422641133100133196700967Mayo Kebbi OuestPala^a^ (15)418,50544^a^175940230040232617012616Mayo Kebbi OuestLéré (16)280,1682368510530010531452001452TandjiléBéré & Kélo^a^ (17)349,34842128431561031552327012326TandjiléDonomanga & Laï^a^ (18)261,50544 ^a^136328430028432592002592Moyen ChariSarh (19)394,519226559560095694301942Moyen ChariDanamadji (20)130,28622648972009721028001028Moyen ChariKyabé (21)214,91322655104100104190001899N'DjamenaSuburbs (22)1 228 3522266013550013551183011182BorkouFaya (23)115,7102262310801110781097241091Ennédi (West & East)Fada & Bahai (24)214,64621591109503109292703924Bahr El GazelMoussoro (25)322,53322650107404107084407837Chari BaguirmiMassenya (26)186,922226469560095689010889Chari BaguirmiDourbali (27)193,30522660100700100796402962Chari BaguirmiBousso (28)195,24222657106110106097501974Hadjer LamisMassakory (29)232,73122655112205111787805873Hadjer LamisMassaguet (30)191,6892267113300013301213001213KanemMao-1 (31)165,06020608106600106685300853KanemMao-2 (32)152,36324729129700129798730984MandoulKoumra (33)242,1592266113840013841289001289MandoulGoundi (34)181,6202265812060012061178001178MandoulMoïssala (35)242,8342266012480012481147001147MandoulBédjondo (36)121,08122659109700109781800818Wadi FiraBiltine (37)301,2632265912590012591430001430Wadi FiraGuéréda (38)192,9182265711240011241649001649Wadi FiraIriba (39)117,7532265913040013041481101480Hadjer LamisBokoro-1 (40)127,6612266514000014001395001395Hadjer LamisBokoro-2 (41)143,9582266814490014491363101362Total8,599,64496729,91056,215143956,16248,528165248,460[^5]10.1080/09286586.2018.1546877-F0001Figure 1.Prevalence of trachomatous inflammation---follicular (TF) in 1--9-year-olds, Global Trachoma Mapping Project, Chad, 2014--2015. Evaluation units are labelled with numbers; the key is found in [Tables 2](#T0002), [3](#T0003) and [4](#T0004).10.1080/09286586.2018.1546877-F0002Figure 2.Prevalence of trichiasis in ≥ 15-year-olds, Global Trachoma Mapping Project, Chad, 2014--2015. Evaluation units are labelled with numbers; the key is found in [Tables 2](#T0002), [3](#T0003) and [4](#T0004).

In total, 104,705 people were enrolled and 104,584 (99%) examined in 29,239 households recruited from 967 clusters ([Table 2](#T0002)). There were almost equal numbers of 1--9-year-olds (*n* = 55,885) and ≥ 15-year-olds (*n* = 48,699) examined. While the sampling process was designed to facilitate examination of at least 1,019 children in each EU, the survey teams in five EUs did not reach this target, with the lowest number of 1--9-year-olds examined in an EU being 956; reports from the field indicated that in many locations, households had fewer resident children than expected.

The adjusted TF prevalence in 1--9-year-old children was ≥ 5% (above the WHO threshold for elimination^[31](#CIT0031)^) in 16 (39%) of the 41 EUs. Five EUs (12%) had TF prevalence estimates of 10--29.9%, and 11 EUs (27%) had TF prevalence estimates of 5--9.9% ([Table 3](#T0003), [Figure 1](#F0001)).10.1080/09286586.2018.1546877-T0003Table 3.Prevalence of trachomatous inflammation---follicular (TF) in 1--9-year-olds, prevalence of trichiasis in ≥ 15-year-olds, backlog of trichiasis cases and number of trichiasis cases needing management to reach the WHO elimination threshold, by evaluation unit, Global Trachoma Mapping Project, Chad, 2014--2015.RegionEvaluation unit (label in [Figures 1](#F0001) and [2](#F0002))TF prevalence^a^, % (95% CI)Trichiasis prevalence^b^, % (95% CI)Estimated backlog of trichiasis cases^c^Estimated number of trichiasis cases needing management to reach WHO elimination thresholdBathaAti (1)10.9 (7.3--14.7)0.57 (0.25--0.98)774499BathaOum Hadjer (2)8.6 (6.0--11.7)0.55 (0.25--0.96)634401BathaYao (3)5.4 (3.4--6.8)0.30 (0.07--0.64)21369Logone OccidentalLaokassy (4)2.5 (1.5--3.5)0.29 (0.07--0.62)15145Logone OccidentalBénoye (5)1.9 (1.1--2.9)0.02 (0.0--0.05)210Logone OrientalDoba (6)5.9 (3.2--9.6)0.14 (0.0--0.38)1910Logone OrientalBéboto (7)3.4 (1.4--6.3)0.15 (0.04--0.30)1020Logone OrientalBébédjia (8)1.3 (0.4--2.4)0.36 (0.10--0.64)278122Logone OrientalGoré (9)3.4 (1.9--5.2)0.72 (0.32--1.27672483Logone OrientalBessao (10)3.9 (2.0--5.9)0.92 (0.26--1.66)1024799Mayo Kebbi EstBongor (11)2.7 (1.5--4.0)0.34 (0.0--0.93)419170Mayo Kebbi EstGounou Gaya (12)2.4 (1.7--3.0)0.08 (0.0--0.20)1140Mayo Kebbi EstGuélengdeng (13)6.0 (2.9--10.1)0.59 0.23--1.09)363238Mayo Kebbi EstFianga (14)1.8 (0.6--3.5)0.14 (0.0--0.33)1990Mayo Kebbi OuestPala (15)6.6 (5.1--8.4)0.20 (0.07--0.36)4130Mayo Kebbi OuestLéré (16)4.5 (2.9--5.6)0.47 (0.09--1.08)650370TandjiléBéré & Kélo (17)0.1 (0.0--0.3)0.06 (0.0--0.16)1040TandjiléDonomanga & Laï (18)0.2 (0.0--0.5)0.50 (0.17--0.94)646384Moyen ChariSarh (19)5.1 (3.1--7.4)0.33 (0.13--0.51)643248Moyen ChariDanamadji (20)4.3 (2.2--6.2)0.17 (0.04--0.36)1090Moyen ChariKyabé (21)7.3 (5.4--8.9)0.93 (0.44--1.49)987772N'DjamenaSuburbs (22)4.2 (2.5--6.6)0.13 (0.0--0.31)7890BorkouFaya (23)10.1 (4.0--19.0)1.21 (0.31--2.01)692576Ennédi (West & East)Fada & Bahai (24)8.5 (4.3--14.2)0.18 (0.0--0.41)1910Bahr El GazelMoussoro (25)0.0 (0.0--0.0)0.60 (0.15--1.25)956633Chari BaguirmiMassenya (26)4.1 (1.6--6.8)0.17 (0.04--0.32)1570Chari BaguirmiDourbali (27)4.9 (2.2--7.6)0.52 (0.22--0.92)497304Chari BaguirmiBousso (28)7.9 (4.1--14.3)0.39 (0.15--0.59)376181Hadjer LamisMassakory (29)0.1 (0.0--0.2)0.45 (0.09--0.83)517284Hadjer LamisMassaguet (30)0.4 (0.1--0.9)0.19 (0.05--0.35)1800KanemMao-1 (31)23.3 (19.0--29.4)0.44 (0.11--0.84)358193KanemMao-2 (32)16.2 (12.7--20.2)0.23 (0.02--0.50)17321MandoulKoumra (33)3.5 (1.8--5.9)0.87 (0.39--1.32)1041799MandoulGoundi (34)11.4 (8.6--15.0)0.55 (0.31--0.95)493311MandoulMoïssala (35)9.8 (7.0--13.8)0.69 (0.29--1.06)828585MandoulBédjondo (36)0.0 (0.0--0.0)0.20 (0.0--0.48)1200Wadi FiraBiltine (37)6.9 (5.4--8.8)1.30 (0.79--1.86)19351634Wadi FiraGuéréda (38)0.3 (0.0--0.6)0.37 (0.11--0.74)353160Wadi FiraIriba (39)1.7 (0.8--2.9)0.31 (0.09--0.60)18062Hadjer LamisBokoro-1 (40)1.1 (0.2--2.4)0.55 (0.11--1.19)347219Hadjer LamisBokoro-2 (41)2.0 (0.5--4.8)0.16 (0.03--0.34)1140Total   19,00410,562[^6][^7][^8][^9]

In 12 EUs (29%), the age- and gender-adjusted trichiasis prevalence was below the WHO elimination threshold^[31](#CIT0031)^ of 0.2% in ≥ 15-year-olds ([Table 3](#T0003), [Figure 2](#F0002)). In the remaining 29 EUs, trichiasis prevalence was ≥ 0.2%. Two EUs had trichiasis prevalence estimates of \> 1%. The estimated number of trichiasis patients requiring management to achieve elimination of trichiasis as a public health problem at the time of conclusion of the surveys was 10,562 ([Table 3](#T0003)).

Analysis of gender-specific age-adjusted trichiasis prevalence estimates revealed mean EU-level prevalences of 0.55% in women and 0.28% in men; in 31 (76%) of the 41 EUs, the prevalence of trichiasis was higher in women than men ([Table 4](#T0004)). There were five EUs in which none of the men examined had trichiasis. The mean ratio of prevalence in women to that in men (excluding the five EUs in which prevalence in men was 0) was 1.70 (SE = 0.53) in the EUs below the WHO elimination threshold, and 2.31 (SE = 0.48) in the EUs above the WHO elimination threshold. A higher prevalence of trichiasis was associated with a greater excess of disease in women (correlation coefficient = 250, SE = 114, *p* = 0.03).10.1080/09286586.2018.1546877-T0004Table 4.Prevalence of trichiasis in males and females aged ≥ 15 years, by evaluation unit, Global Trachoma Mapping Project, Chad, 2014--2015.RegionEvaluation unitTrichiasis prevalence in all ≥ 15-year-olds^a^, % (95% CI)Trichiasis prevalence in ♀ ≥ 15-year-olds^b^, % (95% CI)Trichiasis prevalence in ♂ ≥ 15-year-olds^b^, % (95% CI)Ratio of prevalence in ♀: prevalence in ♂sBathaAti (1)0.57 (0.25--0.98)0.62 (0.17--1.24)0.50 (0.0--1.19)1.2BathaOum Hadjer (2)0.55 (0.25--0.96)0.54 (0.17--1.13)0.56 (0.09--1.30)1.0BathaYao (3)0.30 (0.07--0.64)0.57 (0.14--1.23)0 (0.0--0.0)NALogone OccidentalLaokassy (4)0.29 (0.07--0.62)0.33 (0.05--0.70)0.25 (0.0--0.77)1.3Logone OccidentalBénoye (5)0.02 (0.0--0.05)0.03 (0.0--0.10)0 (0.0--0.0)NALogone OrientalDoba (6)0.14 (0.0--0.38)0.08 (0.0--0.24)0.21 (0.0--0.63)0.4Logone OrientalBéboto (7)0.15 (0.04--0.30)0.08 (0.0--0.19)0.22 (0.0--0.54)0.4Logone OrientalBébédjia (8)0.36 (0.10--0.64)0.30 (0.06--0.52)0.41 (0.0--1.04)0.7Logone OrientalGoré (9)0.72 (0.32--1.271.38 (0.62--2.42)0 (0.0--0.0)NALogone OrientalBessao (10)0.92 (0.26--1.66)1.02 (0.25--1.70)0.81 (0.0--2.30)1.6Mayo Kebbi EstBongor (11)0.34 (0.0--0.93)0.65 (0.0--1.76)0 (0.0--0.0)NAMayo Kebbi EstGounou Gaya (12)0.08 (0.0--0.20)0.07 (0.0--0.17)0.10 (0.0--0.29)0.7Mayo Kebbi EstGuélengdeng (13)0.59 0.23--1.09)0.89 (0.33--1.67)0.26 (0.0--0.69)3.4Mayo Kebbi EstFianga (14)0.14 (0.0--0.33)0.28 (0.0--0.62)0 (0.0--0.0)NAMayo Kebbi OuestPala (15)0.20 (0.07--0.36)0.12 (0.0--0.28)0.27 (0.05--0.59)0.4Mayo Kebbi OuestLéré (16)0.47 (0.09--1.08)0.70 (0.16--1.58)0.21 (0.0--0.56)3.3TandjiléBéré & Kélo (17)0.06 (0.0--0.16)0.07 (0.0--0.20)0.06 (0.0--0.17)1.2TandjiléDonomanga & Laï (18)0.50 (0.17--0.94)0.81 (0.22--1.63)0.16 (0.0--0.43)5.2Moyen ChariSarh (19)0.33 (0.13--0.51)0.30 (0.13--0.54)0.37 (0.0--0.69)0.8Moyen ChariDanamadji (20)0.17 (0.04--0.36)0.15 (0.0--0.34)0.18 (0.0--0.55)0.8Moyen ChariKyabé (21)0.93 (0.44--1.49)1.17 (0.61--1.63)0.67 (0.0--1.53)1.7N'DjamenaSuburbs (22)0.13 (0.0--0.31)0.18 (0.0--0.47)0.08 (0.0--0.20)2.4BorkouFaya (23)1.21 (0.31--2.01)2.15 (0.55--3.63)0.19 (0.0--0.37)11.6Ennédi (West & East)Fada & Bahai (24)0.18 (0.0--0.41)0.27 (0.0--0.63)0.09 (0.0--0.26)3.2Bahr El GazelMoussoro (25)0.60 (0.15--1.25)0.91 (0.15--2.16)0.27 (0.0--0.53)3.4Chari BaguirmiMassenya (26)0.17 (0.04--0.32)0.18 (0.0--0.42)0.15 (0.0--0.40)1.2Chari BaguirmiDourbali (27)0.52 (0.22--0.92)0.68 (0.23--1.31)0.35 (0.0--0.95)1.9Chari BaguirmiBousso (28)0.39 (0.15--0.59)0.41 (0.08--0.67)0.36 (0.08--0.73)1.2Hadjer LamisMassakory (29)0.45 (0.09--0.83)0.55 (0.09--1.00)0.35 (0.0--0.89)1.6Hadjer LamisMassaguet (30)0.19 (0.05--0.35)0.26 (0.03--0.58)0.12 (0.0--0.25)2.1KanemMao-1 (31)0.44 (0.11--0.84)0.51 (0.12--0.89)0.37 (0.0--1.10)1.4KanemMao-2 (32)0.23 (0.02--0.50)0.16 (0.0--0.39)0.30 (0.0--0.77)0.5MandoulKoumra (33)0.87 (0.39--1.32)0.88 (0.28--1.57)0.86 (0.14--1.58)1.0MandoulGoundi (34)0.55 (0.31--0.95)0.73 (0.32--1.34)0.35 (0.09--0.68)2.1MandoulMoïssala (35)0.69 (0.29--1.06)0.83 (0.23--1.36)0.54 (0.08--1.25)1.6MandoulBédjondo (36)0.20 (0.0--0.48)0.30 (0.0--0.69)0.08 (0.0--0.25)3.6Wadi FiraBiltine (37)1.30 (0.79--1.86)1.64 (0.87--2.83)0.90 (0.24--1.52)1.8Wadi FiraGuéréda (38)0.37 (0.11--0.74)0.60 (0.18--1.23)0.13 (0.0--0.38)4.8Wadi FiraIriba (39)0.31 (0.09--0.60)0.40 (0.09--0.88)0.20 (0.0--0.54)2.0Hadjer LamisBokoro-1 (40)0.55 (0.11--1.19)0.44 (0.16--0.83)0.67 (0.0--1.76)0.7Hadjer LamisBokoro-2 (41)0.16 (0.03--0.34)0.26 (0.0--0.61)0.04 (0.0--0.13)6.2[^10][^11]

Discussion {#S0004}
==========

The results of these and previous surveys demonstrate that trachoma is a public health problem in Chad. To move towards elimination of trachoma as a public health problem, AFE interventions should be implemented for at least three years before re-survey for the approximately 887,000 people in the five EUs in which TF prevalence was ≥ 10%, and for at least one year before re-survey for the nearly 2.8 million people in the 11 EUs in which TF prevalence was 5--9.9%. Although we are unable to report our own data on access to water and sanitation, 2017 data released by the Chad Government and UNICEF suggest that region-level proportions of the population with access to potable water are as low as 12% (Ennedi-Est), and that outside N'Djamena, region-level rates of open defecation range from 61 to 93%. These conditions are associated with high risk of active trachoma,^[32](#CIT0032),[33](#CIT0033)^ highlighting the need for the F&E components of the SAFE strategy here.

The TF prevalence estimates from these GTMP-supported surveys are considerably lower than those of previous surveys completed in Chad.^[13](#CIT0013)--[15](#CIT0015)^ There are a number of possible explanations for this. When surveys were first planned here, it would have been logical to choose to start in districts with higher expected burdens of trachoma -- where, in other words, eye health professionals were already aware of cases. There may also, or alternatively, have been a temporal decline in the prevalence of active trachoma in the intervening period,^[34](#CIT0034)--[37](#CIT0037)^ with older surveys reflecting *C. trachomatis* transmission intensities^[38](#CIT0038)^ occurring before more recent improvements in access to water, sanitation and health care. The GTMP's emphasis on standardization of trachoma grading (including grader training and qualification based on examination of real people, rather than projected images^[20](#CIT0020)^) may also have contributed.

Trichiasis is widespread in Chad ([Figure 2](#F0002)), with more than two-thirds of EUs surveyed in 2014--2015 having trichiasis prevalence estimates above the WHO elimination threshold. Establishing a public health-level response to trichiasis throughout the widely dispersed communities in these EUs will require considerable capacity building for delivery of high-quality trichiasis surgery and programme management, as well as community-based efforts to generate awareness and encourage uptake of services.^[39](#CIT0039),[40](#CIT0040)^ The excess burden of trichiasis among females ([Table 4](#T0004)), also noted elsewhere,^[25](#CIT0025),[41](#CIT0041),[42](#CIT0042)^ compels us to ensure that such efforts particularly serve women. Experience in other countries can inform strategies to improve use of eye care services by women.^[43](#CIT0043),[44](#CIT0044)^ The association noted here between higher prevalence of trichiasis and greater ratio of trichiasis prevalence in women to trichiasis prevalence in men cannot be explained from our data alone. We note that this was not a pre-specified hypothesis of the current work, and suggest only that further investigation is indicated.

Our work has a number of limitations. First, in five EUs, we did not quite reach the estimated sample size requirement. We report confidence intervals here, however, which facilitates objective assessment of the likely repeatability of our estimates. In future surveys in Chad, the sampling approach will be revised slightly to reflect the smaller-than-expected mean number of children encountered per household. Second, we recruited these marginally low numbers of examinees despite what was apparently an extraordinarily high enrolment rate: 99% of enumerated residents. We wonder whether field teams, fearing criticism for incomplete enrolment, may have failed to register absentees: anecdotally, this occurred in other constituent projects of the GTMP, but obtaining definitive proof was difficult.^[20](#CIT0020)^ Third, this survey work was commenced prior to the inclusion of examination for trachomatous conjunctival scarring (TS^[4](#CIT0004)^) in standard GTMP protocols,^[45](#CIT0045)^ as later recommended by a global scientific meeting.^[29](#CIT0029)^ It is therefore likely that some of the trichiasis cases included in our prevalence estimates were due to conditions other than trachoma^[28](#CIT0028),[29](#CIT0029)^; this may explain part of the association between the overall prevalence of trichiasis and the ratio of gender-specific prevalence estimates. We also did not ask about previous management of trichiasis, so the trichiasis prevalence estimates reported here include both cases known and unknown to the health system.^[19](#CIT0019)^ These refinements can be helpful in influencing whether or not public-health-level interventions are needed against trichiasis.^[46](#CIT0046)^ Fourth, as noted in the results section, three EU pairs were combined at the data cleaning stage; the main implication of this is that the resulting EU populations (like that for N'Djamena suburbs) are larger than the recommended 100,000--250,000 people.^[19](#CIT0019)^ Fifth, as also already noted, data from two EUs in Moundou, Logone Occidental Region, could not be approved due to missing GPS data; as a consequence, results from this EU are not included in the current report. Sixth, because household-level questions were not used as set out in the survey protocol, we are unable to report data on access to water and sanitation. Though unfortunate, as much as this situation reveals a weakness in one part of fieldwork execution, it also demonstrates strength in fieldwork supervision.

Subsequent to completing these surveys, in addition to expanding SAFE interventions, the Ministry of Health commenced planning to re-map Moundou as well as to undertake mapping in some of, but not all, the EUs in which surveys were not attempted in 2014--2015. Undertaking those surveys will contribute to the completion of nationwide mapping of suspected-trachoma-endemic areas of Chad, and help chart a course towards national elimination of trachoma as a public health problem.^[47](#CIT0047)^
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[^1]: Color versions of one or more of the figures in the article can be found online at [www.tandfonline.com/iope](http://www.tandfonline.com/IOPE).

[^2]: See Appendix.

[^3]: ^a^Indicators of severe active trachoma in WHO's 1981 revision of the "FPC" grading system^[16](#CIT0016)^

[^4]: ^b^Unadjusted

    TF, trachomatous inflammation---follicular; TI, trachomatous inflammation---intense

[^5]: ^a^Intended to be mapped as two EUs (please see text)

[^6]: ^a^Adjusted for age in 1-year age bands (see text)

[^7]: ^b^Adjusted for gender and age in 5-year age bands (see text)

[^8]: ^c^Backlog calculated as prevalence × population × proportion of population aged ≥ 15 years (0.494)

[^9]: ^d^Number of cases needing management to reach WHO elimination threshold calculated as backlog -- (0.002 × population aged ≥ 15 years)

    CI, confidence interval

[^10]: ^a^Adjusted for gender and age in 5-year age bands (see text)

[^11]: ^b^Adjusted for age in 5-year age bands (see text)

    CI, confidence interval; NA, not applicable
